Clinical study on thyroid autoantibody abnormality of AITD patients with normal thyroid function of Qi-stagnation constitution by comprehensive constitution intervention

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054144

Enrollment

Unknown

Registered

2021-12-09

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune thyroid disease

Interventions

Xiaoyaosan Group:Xiaoyaosan granules for oral administration

The control group:TCM placebo granule

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18-65 years old; 2. Comply with AITD western medicine diagnostic criteria; 3. Normal thyroid function and positive autoantibodies; 4. The constitution is identified as qi stagnation constitution; 5. Able to accept follow-up and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with acute infection, severe cardiovascular and cerebrovascular diseases, and liver and kidney dysfunction; ? 2. Those in pregnancy and perinatal state; ? 3. Thyroid malignant tumor; 4. Those with mental illness or unable to cooperate with communication.

Design outcomes

Primary

Measure	Time frame
thyroid hormones;thyroid autoantibodys;Th1/Th2 cytokine detection;	—

Secondary

Measure	Time frame
routine urine test;routine blood test;kidney function;liver function;	—

Countries

China

Contacts

Public ContactJiang Min

Beijing Shijitan Hospital

jiangm1965@sina.com+86 13311108797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026